Since the late 1980s, the Harvard School of Public Health AIDS Initiative (HAI) has been at the forefront of HIV/AIDS research, education and leadership.
[1][2] Chaired by noted researcher Max Essex, HAI is currently involved in studies to examine drug resistance in patients taking antiretroviral drugs; vaccine development; prevention of HIV transmission from mother-to-infant in utero, as well as through breast feeding; and cost-effectiveness of treatment programs.
At Harvard, trainees study epidemiology, biostatistics, immunology, molecular biology or behavioral sciences, then return to their home countries to continue their research.
Participants have come from Botswana, Senegal, Tanzania, Thailand, India, Kenya, and Mexico.
KITSO is a collaboration of the Botswana Ministry of Health and the Botswana-Harvard AIDS Institute.